stockrowMerit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024.
- Revenue
- +8.35%
- EPS
- +50.5%
- Free cash flow
- +50.2%
- Total debt
- +0.61%
Quarter to September 2026, against a year earlier
Follow MMSI
Alert me
Merit Medical Systems, Inc. (MMSI) EBITDA
Merit Medical Systems, Inc.'s EBITDA for fiscal 2025 was $324.9M, up 17.3% from $277.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $359.6M. Over the past ten years it has ranged from $75.8M (fiscal 2015) to $324.9M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 5 consecutive fiscal years. Merit Medical Systems, Inc. ranks 16th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $324.9M | 17.26% |
| FY2024 | $277.1M | 22.15% |
| FY2023 | $226.8M | 25.85% |
| FY2022 | $180.3M | 14.67% |
| FY2021 | $157.2M | 48.68% |
| FY2020 | $105.7M | (12.17%) |
| FY2019 | $120.4M | (6.56%) |
| FY2018 | $128.8M | 47.75% |
| FY2017 | $87.2M | 9.79% |
| FY2016 | $79.4M | 4.79% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $95.0M | (0.80%) |
| Jun 2026 | $95.8M | 21.37% |
| Mar 2026 | $78.9M | (12.25%) |
| Dec 2025 | $89.9M | 14.91% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $801.0M |
| NVST Envista Holdings Corporation compare | $428.9M |
| MMSI Merit Medical Systems, Inc. | $359.6M |
| STVN Stevanato Group S.p.A. compare | $351.1M |
| ICUI ICU Medical, Inc. compare | $314.2M |
| TFX Teleflex Incorporated compare | $256.2M |
| ATRC AtriCure, Inc. compare | $34.2M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
| PLSE Pulse Biosciences, Inc compare | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on MMSI
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement